{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:43:43Z","timestamp":1789911823395,"version":"4.0.1"},"reference-count":59,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Hepatitis C virus (HCV) infection is a major public health problem in the European Union (EU). An estimated 5.6 million Europeans are chronically infected with a wide range of variation in prevalence across European Union countries. Although HCV continues to spread as a largely \u201csilent pandemic,\u201d its elimination is made possible through the availability of the new antiviral drugs and the implementation of prevention practices. On 17 February 2016, the Hepatitis B &amp; C Public Policy Association held the first EU HCV Policy Summit in Brussels. This summit was an historic event as it was the first high\u2010level conference focusing on the elimination of HCV at the European Union level. The meeting brought together the main stakeholders in the field of HCV: clinicians, patient advocacy groups, representatives of key institutions and regional bodies from across European Union; it served as a platform for one of the most significant disease elimination campaigns in Europe and culminated in the presentation of the HCV Elimination Manifesto, calling for the elimination of HCV in Europe by 2030. The launch of the Elimination Manifesto provides a starting point for action in order to make HCV and its elimination in Europe an explicit public health priority, to ensure that patients, civil society groups and other relevant stakeholders will be directly involved in developing and implementing HCV elimination strategies, to pay particular attention to the links between hepatitis C and social marginalization and to introduce a European Hepatitis Awareness Week.<\/jats:p>","DOI":"10.1111\/jvh.12875","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T12:15:38Z","timestamp":1520338538000},"page":"6-17","source":"Crossref","is-referenced-by-count":70,"title":["Hepatitis C: The beginning of the end\u2014key elements for successful European and national strategies to eliminate HCV in Europe"],"prefix":"10.1111","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3518-4060","authenticated-orcid":false,"given":"G. V.","family":"Papatheodoridis","sequence":"first","affiliation":[{"name":"Medical School of National Kapodistrian University of Athens  Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hatzakis","sequence":"additional","affiliation":[{"name":"Medical School of National Kapodistrian University of Athens  Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3645-582X","authenticated-orcid":false,"given":"E.","family":"Cholongitas","sequence":"additional","affiliation":[{"name":"Medical School of National Kapodistrian University of Athens  Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Baptista\u2010Leite","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences Cat\u00f3lica University of Portugal  Lisbon Portugal"},{"name":"Faculty of Health, Medicine and Life Sciences Maastricht University  Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Baskozos","sequence":"additional","affiliation":[{"name":"Ministry of Health  Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8741-4430","authenticated-orcid":false,"given":"J.","family":"Chhatwal","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital\u2019 s Institute for Technology Assessment and Harvard Medical School  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Colombo","sequence":"additional","affiliation":[{"name":"Clinical and Research Center Humanitas  Rozzano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Cortez\u2010Pinto","sequence":"additional","affiliation":[{"name":"European Association for the Study of the Liver  Geneva Switzerland"},{"name":"Faculdade de Medicina Universidade de Lisbon  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Craxi","sequence":"additional","affiliation":[{"name":"University of Palermo  Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences Glasgow Caledonian University  Glasgow Scotland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gore","sequence":"additional","affiliation":[{"name":"Hepatitis C Trust World Hepatitis Alliance  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kautz","sequence":"additional","affiliation":[{"name":"Leberhilfe Projekt gUG  Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9618-2299","authenticated-orcid":false,"given":"J. V.","family":"Lazarus","sequence":"additional","affiliation":[{"name":"Barcelonai Institute for Global Health (ISGlobal) Hospital Cl\u00ednic University of Barcelona  Barcelona Spain"},{"name":"CHIP, Rigshospitalet University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mend\u00e3o","sequence":"additional","affiliation":[{"name":"Portuguese Activist Group for HIV\/AIDS Treatment  Lisbon Portugal"},{"name":"European AIDS Treatment Group  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Peck\u2010Radosavljevic","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Gastroenterology  Klagenfurt Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Razavi","sequence":"additional","affiliation":[{"name":"Center for Disease Analysis  Lafayette CO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schatz","sequence":"additional","affiliation":[{"name":"Correlation Network  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"T\u00f6z\u00fcn","sequence":"additional","affiliation":[{"name":"Acibadem Mehmet Ali Aydinlar University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"van Damme","sequence":"additional","affiliation":[{"name":"Antwerp University  Antwerp Belgium"},{"name":"Viral Hepatitis Prevention Board  Antwerp Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wedemeyer","sequence":"additional","affiliation":[{"name":"Hannover Medical School  Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yazdanpanah","sequence":"additional","affiliation":[{"name":"INSERM Universit\u00e9 Paris Diderot  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zuure","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Research and Prevention Public Health Service of Amsterdam  Amsterdam The Netherlands"},{"name":"Department of Internal Medicine Amsterdam Infection and Immunity Institute (AI&amp;II) Academic Medical Center University of Amsterdam  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Manns","sequence":"additional","affiliation":[{"name":"Hannover Medical School  Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"e_1_2_15_2_1","unstructured":"MannsMP.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_3_1","unstructured":"HantzakisA.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_4_1","unstructured":"SchatzE.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_5_1","unstructured":"BusoiC.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_6_1","unstructured":"Cortez\u2010PintoH.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_7_1","unstructured":"ReicT.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_8_1","unstructured":"WHO.Global Hepatitis Report 2017."},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268817001947"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268813000940"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.005"},{"key":"e_1_2_15_12_1","article-title":"EASL recommendations on treatment of hepatitis C","author":"European Association for the Study of the Liver","year":"2016","journal-title":"J Hepatol"},{"key":"e_1_2_15_13_1","unstructured":"Hepatitis B & C Public Policy Association.2016.Hepatitis C\u2010free Europe is possible by 2030 PR."},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61097-0"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.98"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2012.09.012"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26141"},{"key":"e_1_2_15_18_1","unstructured":"AndriukaitisV.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.07.005"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328338d9aa"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12370"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27950"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit302"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2014.08.014"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-16"},{"key":"e_1_2_15_26_1","unstructured":"Declaration on the importance of civil society involvement to eliminate hepatitis C. Amsterdam 2017 http:\/\/www.correlation-net.org\/images\/stories\/pdfs\/pdf_news\/declaration_web.pdf"},{"key":"e_1_2_15_27_1","unstructured":"RazaviH.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_28_1","unstructured":"WiktorS.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_29_1","unstructured":"ChhatwalJ.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0095"},{"key":"e_1_2_15_31_1","unstructured":"KautzA.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_32_1","unstructured":"RyanJ.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13614"},{"key":"e_1_2_15_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13679"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.09.015"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14271"},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30284-4"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.054"},{"key":"e_1_2_15_39_1","unstructured":"MichelsI.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_40_1","unstructured":"YazdanpanahY.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126920"},{"key":"e_1_2_15_42_1","unstructured":"GoldbergD.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_43_1","unstructured":"MendaoL.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_44_1","unstructured":"ZuureF.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_45_1","unstructured":"BaskozosI.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12253"},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-72"},{"key":"e_1_2_15_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-845"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12125"},{"key":"e_1_2_15_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.01912.x"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000208"},{"key":"e_1_2_15_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000126"},{"key":"e_1_2_15_53_1","unstructured":"MozalevskisA.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_54_1","unstructured":"DuffellE.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_55_1","unstructured":"GoosdellA.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_56_1","unstructured":"European Monitoring Center for Drugs and Addiction (EMCDDA).Drug Related Infectious Diseases in Europe. Available at:http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/1815\/TD0215722ENN.pdf. 2015."},{"key":"e_1_2_15_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12314"},{"key":"e_1_2_15_58_1","unstructured":"DeBacker P.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_59_1","unstructured":"GoreC.Presentation at EU HCV Policy Summit.2016."},{"key":"e_1_2_15_60_1","unstructured":"CraxiA.Presentation at EU HCV Policy Summit.2016."}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12875","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T07:57:00Z","timestamp":1694591820000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":59,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1111\/jvh.12875"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12875","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}